Amplitude Healthcare Acquisition Corp. (AMHC)
| Market Cap | 123.75M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -590,701 |
| Shares Out | 10.00M |
| EPS (ttm) | -0.29 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 11 |
| Last Price | $9.93 |
| Previous Close | $9.91 |
| Change ($) | 0.02 |
| Change (%) | 0.15% |
| Day's Open | 9.91 |
| Day's Range | 9.88 - 9.94 |
| Day's Volume | 333,051 |
| 52-Week Range | 9.70 - 10.50 |
Last week featured five announced SPAC deals and several rumors. The week also had earnings from several well-known former SPACs.
Biotech firm, Jasper Therapeutics Inc, is planning to go public via a reverse SPAC merger deal with Amplitude Healthcare Acquisition Corp (NASDAQ: AMHC) in a $100 million deal.
REDWOOD CITY, Calif., & NEW YORK--(BUSINESS WIRE)--Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, and Amplitude Healthcare Acquisition Corporation...
About AMHC
Amplitude Healthcare Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to focus on the life sciences and pharmaceutical services sectors in the United States and Europe. Amplitude Healthcare Acquisition Corporation was incorporated in 2019 and is based in New York, New York.
| Industry Shell Companies | IPO Date Nov 20, 2019 |
| Stock Exchange NASDAQ | Ticker Symbol AMHC |